Question 1

Which ETFs are similar to Nippon India Nifty Pharma ETF-Growth?

Accepted Answer

ETFs similar to Nippon India Nifty Pharma ETF-Growth in the Equity: Sectoral-Pharma category include ICICI Prudential Nifty Healthcare ETF-Growth, Groww BSE Hospitals ETF-Growth, and Aditya Birla Sun Life Nifty Healthcare ETF-Growth. These ETFs follow a comparable investment mandate and are benchmarked against similar indices. You can compare them in detail — across returns, risk metrics, expense ratio, and portfolio composition — using the ETF comparison tool on sharpely.

Question 2

What is the rank of Nippon India Nifty Pharma ETF-Growth in its category?

Accepted Answer

On a 3-year return basis Nippon India Nifty Pharma ETF-Growth is ranked 5 out of 17 ETFs in the Equity: Sectoral-Pharma category as of 12 Oct 2026. On a 5-year return basis it ranks 5 out of 11. Consistently ranking in the top across multiple time periods is a stronger signal of ETF quality than a single-period rank.

Question 3

How does Nippon India Nifty Pharma ETF-Growth's expense ratio compare to similar ETFs?

Accepted Answer

Nippon India Nifty Pharma ETF-Growth has an expense ratio of 0.23%. The peers ICICI Prudential Nifty Healthcare ETF-Growth has an expense ratio of 0.18% and Groww BSE Hospitals ETF-Growth has 0.55%. Over the long term, a higher expense ratio can meaningfully drag on returns, so it is worth evaluating whether the ETF's performance justifies the additional cost.

Question 4

How does Nippon India Nifty Pharma ETF-Growth's AUM compare to similar ETFs?

Accepted Answer

Nippon India Nifty Pharma ETF-Growth has an AUM of ₹1,736.44 crore. The peers ICICI Prudential Nifty Healthcare ETF-Growth has an AUM of ₹231.43 crore and Groww BSE Hospitals ETF-Growth has ₹159.92 crore. A large AUM can sometimes limit a ETF's ability to take meaningful positions in mid and small-cap stocks, as larger trades can move prices. This is particularly relevant for ETFs that invest outside large caps.

Question 5

Which ETF has the best 3-year returns in the Equity: Sectoral-Pharma?

Accepted Answer

The top performing ETF in the Equity: Sectoral-Pharma category on a 3-year basis is Motilal Oswal BSE Healthcare ETF-Growth with a CAGR of 20.21% as of 12 Oct 2026. Nippon India Nifty Pharma ETF-Growth has delivered 20.08% CAGR over the same period, ranking 5 out of 17 ETFs. You can view and compare the full category ranking on sharpely.

Question 6

How does Nippon India Nifty Pharma ETF-Growth rank in risk-adjusted returns vs peers?

Accepted Answer

On a risk-adjusted basis, Nippon India Nifty Pharma ETF-Growth has a Sharpe ratio of 0.87 compared to the Equity: Sectoral-Pharma average of 0.82 as of 12 Oct 2026. It ranks 2 out of 5 ETFs in its category on Sharpe ratio.

Period	This Fund	Category Avg	Category Rank
1Y Return	+17.85%	9.79%	3 / 27
3Y Return	+20.08%	19.13%	5 / 17
5Y Return	+12.73%	12.84%	5 / 11
10Y Return	—	13.32%	—

Nippon India Nifty Pharma ETF-Growth

Similar ETFs

ETFs in Equity: Sectoral-Pharma

ETFs Tracking NIFTY Pharma Total Return Index

Frequently Asked Questions

ETFs in Equity: Sectoral-Pharma

ETFs Tracking NIFTY Pharma Total Return Index

Frequently Asked Questions